Skip to main content
. 2015 Nov 6;38(11):941–949. doi: 10.14348/molcells.2015.2353

Fig. 4.

Fig. 4.

Rocaglamide-A affects the formation of mineralized osteoblast nodules. (A) The 30 nM ROC-A blocked the suppression of nodule formation from 10 ng/ml TNF-α; (B) The quantification of Fig. 4A (n > 3, **p < 0.01). (C) 30 nM ROC-A stimulated the ODM induced mesenchymal stromal cell nodule formation; (D) The quantification of Fig. 4C (n > 3, *p < 0.05).